您的位置: 首页 > 农业专利 > 详情页

Dosing regimen for janus kinase (jak) inhibitors
专利权人:
ZOETIS LLC
发明人:
GONZALES ANDREA J.,COSGROVE SALLIE B.,MALPAS PHYLLIS B.,STEGEMANN MICHAEL ROLF,COLLARD WENDY TURNER
申请号:
NZ70315213
公开号:
NZ703152A
申请日:
2013.07.18
申请国别(地区):
NZ
年份:
2016
代理人:
摘要:
The present invention provides a method for treating allergic dermatitis, atopic dermatitis, or one or more symptoms thereof in a dog in need, which method comprises administering to the dog a first therapeutically effective dose of the Janus Kinase-1 (JAK-1) inhibitor, N-methyl-1-{ trans-4-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclohexyl} methanesulfonamide or a pharmaceutically acceptable salt thereof, twice a day for up to 14 days followed by a second once-a-day therapeutic effective dose of the JAK-1 inhibitor for up to 112 days.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充